Recent News

• 02.05.2025 - Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025
• 12.20.2024 - Aadi Bioscience, Inc. Investor Call
• 12.19.2024 - Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing
• 12.19.2024 - Baiteng Zhao, PhD

Recent Filings

• 02.05.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 02.04.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 01.31.2025 - DEFM14A Definitive proxy statement relating to merger or acquisition
• 01.29.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 01.21.2025 - PREM14A Preliminary proxy statements relating to merger or acquisition
• 12.23.2024 - 4 Statement of changes in beneficial ownership of securities
• 12.23.2024 - 3 Initial statement of beneficial ownership of securities
• 12.20.2024 - EX-99.1 EX-99.1
• 12.20.2024 - 8-K Current report